PLAT and ischemic stroke: So far, the only drug approved by FDA for treating ischemic stroke is tissue plasminogen activator (tPA), which breaks down the blood vessel clot.8 This therapy has several limitations, such as the therapeutic window is only 4.5 h, and treatment outside the therapeutic window could possibly result in cerebral hemorrhage.330 Progress have been made in discovering new therapeutic approaches against ischemic stroke.